Data in Lupus: Digital Therapeutic Improves Executive Function in Patients

Akili Interactive Labs, Inc. announced the publication of full data from a randomized, unblinded study that evaluated the ability of Akili’s digital therapeutic, AKL-T01, to improve cognitive dysfunction in patients diagnosed with Systemic Lupus Erythematosus (SLE). The study results showed significant improvement in motor and speed executive functions. Based on the results of this study, they are consistent with the cognitive improvements seen in other studies previously done outside of the company for patients with SLE after using digital therapeutic engine. AKL-T01 is delivered to patients through an interactive video game experience designed to target the neural systems that play a key role in attention function while using adaptive algorithms to personalize the treatment.

Read more about this news release here.